These findings suggest that AXL expression in the primary tumor is an independent prognostic marker of poor prognosis in ES, which was confirmed in a Cox multivariate regression analysis (p = 0.021)(Supplemental Table 1). The gene discussed is AXL; the disease is Ewing sarcoma.